Non-Alcoholic Fatty Liver Disease, An Issue of Clinics in Liver Disease
Due to the current obesity epidemic, non-alcoholic fatty liver disease (NAFLD) is prevalent in a significant portion of the United States patient population. It is being increasingly recognized that NAFLD affects both adults and children and can progress to...
Leider schon ausverkauft
138.99 €
versandkostenfrei
Produktdetails
Produktinformationen zu „Non-Alcoholic Fatty Liver Disease, An Issue of Clinics in Liver Disease “
Weitere Produktinformationen zu „Non-Alcoholic Fatty Liver Disease, An Issue of Clinics in Liver Disease “
Due to the current obesity epidemic, non-alcoholic fatty liver disease (NAFLD) is prevalent in a significant portion of the United States patient population. It is being increasingly recognized that NAFLD affects both adults and children and can progress to end stage liver disease with resultant cirrhosis, portal hypertension, and hepatocellular carcinoma. In addition, several extrahepatic conditions may be linked to NAFLD including cardiovascular disease, insulin requiring and type 2 diabetes mellitus, obstructive sleep apnea, colonic adenomas, hyperuricemia, vitamin D deficiency, hyperferritinemia, pancreatic steatosis, hypothyroidism, and polycystic ovarian syndrome. Therapies for NAFLD are evolving rapidly. This issue will analyze patient demographics, risk factors, pathophysiology, patient presentation, and treatments for NAFLD.
Bibliographische Angaben
- Autor: Paul J. Gaglio
- Verlag: ELSEVIER HEALTH SCIENCE
- EAN: 9780323416962
Kommentar zu "Non-Alcoholic Fatty Liver Disease, An Issue of Clinics in Liver Disease"
0 Gebrauchte Artikel zu „Non-Alcoholic Fatty Liver Disease, An Issue of Clinics in Liver Disease“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Non-Alcoholic Fatty Liver Disease, An Issue of Clinics in Liver Disease".
Kommentar verfassen